The role of regulatory T cells in atopic dermatitis

Current Problems in Dermatology

Volumn 41, Issue , 2011, Pages 112-124

  Agrawal, Rachana ^a   Wisniewski, Julia A ^a   Woodfolk, Judith A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; FOOD ALLERGEN;

ALLERGIC DISEASE; ALLERGIC REACTION; ARTICLE; ATOPIC DERMATITIS; ECZEMA; EVIDENCE BASED PRACTICE; FOOD ALLERGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MOLECULAR BIOLOGY; PATHOGENESIS; POLLEN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH2 CELL;

ALLERGENS; BIOLOGICAL MARKERS; DERMATITIS, ATOPIC; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYPERSENSITIVITY; INFLAMMATION MEDIATORS; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES, REGULATORY; TH2 CELLS;

EID: 84925970431     PISSN: 14215721     EISSN: 16622944     Source Type: Book Series    
DOI: 10.1159/000323305     Document Type: Article

References (78)

1. Shevach EM: From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 2006;25: 195-201. (Pubitemid 44224153)
2. Gavin MA, Torgerson TR, Houston E, De Roos P, Ho WY, Stray-Pedersen A, et al: Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA. 2006;103: 6659-6664.
3. Pillai V, Ortega SB, Wang CK, Karandikar NJ: Transient regulatory T-cells: a state attained by all activated human T-cells. Clin Immunol 2007;123: 18-29. (Pubitemid 46401504)
4. Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, et al: Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007; 19:345-354. (Pubitemid 46523383)
5. Baron U, Floess S, Wieczorek G, Baumann K, Grutzkau A, Dong J, et al: DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells. Eur J Immunol 2007;37:2378-2389. (Pubitemid 47423608)
6. Janson PC, Winerdal ME, Marits P, Thorn M, Ohlsson R, Winqvist O: FOXP3 promoter demethylation reveals the committed Treg population in humans. PLoS One 2008;3:e1612.
7. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, et al: CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006;203:1701-1711. (Pubitemid 44036276)
8. Bayry J, Triebel F, Kaveri SV, Tough DF: Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cells. J Immunol 2007;178:4184-4193. (Pubitemid 46492369)
9. Clark RA, Kupper TS: IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. Blood 2007;109: 194-202. (Pubitemid 46053061)
10. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH: Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001;193:1285-1294. (Pubitemid 32524778)
11. Wang R, Kozhaya L, Mercer F, Khaitan A, Fujii H, Unutmaz D: Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells. Proc Natl Acad Sci USA 2009;106:13439-13444.
12. Stockis J, Colau D, Coulie PG, Lucas S: Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg. Eur J Immunol 2009;39:3315-3322.
13. Probst-Kepper M, Geffers R, Kroger A, Viegas N, Erck C, Hecht HJ, et al: GARP: a key receptor controlling FOXP3 in human regulatory T cells. J Cell Mol Med 2009;13:3343-3357.
14. Wang R, Wan Q, Kozhaya L, Fujii H, Unutmaz D: Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression. PLoS One 2008;3: e2705.
15. Probst-Kepper M, Balling R, Buer J: FOXP3: required but not sufficient -the role of GARP (LRRC32) as a safeguard of the regulatory phenotype. Curr Mol Med 2010;10:533-539.
16. Probst-Kepper M, Buer J: FOXP3 and GARP (LRRC32): the master and its minion. Biol Direct 2010;5:8.
17. Tran DQ, Andersson J, Hardwick D, Bebris L, Illei GG, Shevach EM: Selective expression of latencyassociated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures. Blood 2009;113:5125-5133.
18. Gandhi R, Farez MF, Wang Y, Kozoriz D, Quintana FJ, Weiner HL: Cutting edge: human latencyassociated peptide+ T cells: a novel regulatory T cell subset. J Immunol 2010;184:4620-4624.
19. Tran DQ, Shevach EM: Therapeutic potential of FOXP3+ regulatory T cells and their interactions with dendritic cells. Hum Immunol 2009;70: 294-299.
20. Shevach EM: Mechanisms of Foxp3+ T regulatory cell-mediated suppression. Immunity 2009;30: 636-645.
21. Bettini M, Vignali DA: Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol 2009;21:612-618.
22. Wan YY: Multi-tasking of helper T cells. Immunology 2010;130:166-171.
23. Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y, Kas A, et al: CD4+ regulatory T cells control Th17 responses in a Stat3-dependent manner. Science 2009;326:986-991.
24. Zheng Y, Chaudhry A, Kas A, de Roos P, Kim JM, Chu TT, et al: Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control Th2 responses. Nature 2009;458:351-356.
25. Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergenspecific T regulatory 1 and T helper 2 cells. J Exp Med 2004;199:1567-1575. (Pubitemid 38780411)
26. Hartl D, Koller B, Mehlhorn AT, Reinhardt D, Nicolai T, Schendel DJ, et al: Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol 2007;119:1258-1266. (Pubitemid 46654192)
27. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, et al: Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999;341:468-475. (Pubitemid 29372886)
28. O'Hehir RE, Gardner LM, de Leon MP, Hales BJ, Biondo M, Douglass JA, et al: House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells. Am J Respir Crit Care Med 2009;180:936-947.
29. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, et al: IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003;33: 1205-1214. (Pubitemid 36609138)
30. Francis JN, Till SJ, Durham SR: Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003;111: 1255-1261. (Pubitemid 36683679)
31. Meiler F, Zumkehr J, Klunker S, Ruckert B, Akdis CA, Akdis M: In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 2008;205:2887-2898.
32. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K: Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998;102:98-106. (Pubitemid 28323835)
33. Nouri-Aria KT, Wachholz PA, Francis JN, Jacobson MR, Walker SM, Wilcock LK, et al: Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol 2004;172:3252-3259. (Pubitemid 38263717)
34. Platts-Mills T, Vaughan J, Squillace S, Woodfolk J, Sporik R: Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet 2001;357:752-756. (Pubitemid 32217683)
35. Reefer AJ, Carneiro RM, Custis NJ, Platts-Mills TA, Sung SS, Hammer J, et al: A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen. J Immunol 2004;172:2763-2772. (Pubitemid 38263659)
36. Novak N, Tepel C, Koch S, Brix K, Bieber T, Kraft S: Evidence for a differential expression of the FcåRIã chain in dendritic cells of atopic and nonatopic donors. J Clin Invest 2003;111: 1047-1056. (Pubitemid 36397481)
37. Trompette A, Divanovic S, Visintin A, Blanchard C, Hegde RS, Madan R, et al: Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 2009;457:585-588.
38. Aumeunier A, Grela F, Ramadan A, Pham Van L, Bardel E, Gomez Alcala A, et al: Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice. PLoS One 2010;5:e11484.
39. Abdollahi-Roodsaz S, Joosten LA, Koenders MI, Devesa I, Roelofs MF, Radstake TR, et al: Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 2008;118:205-216.
40. Pulendran B, Tang H, Manicassamy S: Programming dendritic cells to induce Th2 and tolerogenic responses. Nat Immunol 2010;11:647-655.
41. Hulse KE, Reefer AJ, Engelhard VH, Patrie JT, Ziegler SF, Chapman MD, et al: Targeting allergen to FcgammaRI reveals a novel Th2 regulatory pathway linked to thymic stromal lymphopoietin receptor. J Allergy Clin Immunol 2010;125:247-256.
42. Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD, et al: Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells. Blood 2001;98:2736-2744.
43. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G: Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood. J Exp Med 2001;193:1303-1310. (Pubitemid 32524780)
44. Levings MK, Sangregorio R, Roncarolo MG: Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001;193:1295-1302.
45. Reefer AJ, Satinover SM, Solga MD, Lannigan JA, Nguyen JT, Wilson BB, et al: Analysis of CD25hiCD4+ 'regulatory' T-cell subtypes in atopic dermatitis reveals a novel Th2-like population. J Allergy Clin Immunol 2008;121:415-422.
46. Clark RA, Chong B, Mirchandani N, Brinster NK, Yamanaka K, Dowgiert RK, et al: The vast majority of CLA+ T cells are resident in normal skin. J Immunol 2006;176:4431-4439. (Pubitemid 44264423)
47. Hirahara K, Liu L, Clark RA, Yamanaka K, Fuhlbrigge RC, Kupper TS: The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors. J Immunol 2006;177:4488-4494. (Pubitemid 44469779)
48. Kupper TS, Fuhlbrigge RC. Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 2004;4:211-222. (Pubitemid 38339087)
49. Thepen T, Langeveld-Wildschut EG, Bihari IC, van Wichen DF, van Reijsen FC, Mudde GC, et al: Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial Th2 response to a Th1 response in situ: an immunocytochemical study. J Allergy Clin Immunol 1996;97: 828-837. (Pubitemid 26089257)
50. Grewe M, Bruijnzeel-Koomen CA, Schopf E, Thepen T, Langeveld-Wildschut AG, Ruzicka T, et al: A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998;19:359-361. (Pubitemid 28392277)
51. Eyerich K, Pennino D, Scarponi C, Foerster S, Nasorri F, Behrendt H, et al: IL-17 in atopic eczema: linking allergen-specific adaptive and microbialtriggered innate immune response. J Allergy Clin Immunol 2009;123:59-66.
52. Verhagen J, Akdis M, Traidl-Hoffmann C, Schmid-Grendelmeier P, Hijnen D, Knol EF, et al: Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 2006;117:176-183. (Pubitemid 43017157)
53. Caproni M, Antiga E, Torchia D, Volpi W, Barletta E, Gitti G, et al: Foxp3-expressing T regulatory cells in atopic dermatitis lesions. Allergy Asthma Proc 2007;28:525-528.
54. Szegedi A, Barath S, Nagy G, Szodoray P, Gal M, Sipka S, et al: Regulatory T cells in atopic dermatitis: epidermal dendritic cell clusters may contribute to their local expansion. Br J Dermatol 2009;160: 984-993.
55. Fujimura T, Okuyama R, Ito Y, Aiba S: Profiles of Foxp3+ regulatory T cells in eczematous dermatitis, psoriasis vulgaris and mycosis fungoides. Br J Dermatol 2008;158:1256-1263. (Pubitemid 351692856)
56. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001;27:20-21. (Pubitemid 32044513)
57. Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, et al: JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2000;106:R75-R81. (Pubitemid 32038594)
58. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, et al: X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001;27:18-20. (Pubitemid 32044512)
59. Ker J, Hartert TV: The atopic march: what's the evidence? Ann Allergy Asthma Immunol 2009;103: 282-289.
60. Karlsson MR, Rugtveit J, Brandtzaeg P: Allergenresponsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 2004;199:1679-1688. (Pubitemid 38822001)
61. Shreffler WG, Wanich N, Moloney M, Nowak-Wegrzyn A, Sampson HA: Association of allergenspecific regulatory T cells with the onset of clinical tolerance to milk protein. J Allergy Clin Immunol 2009;123:43-52.
62. Ou LS, Goleva E, Hall C, Leung DY: T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol 2004;113:756-763. (Pubitemid 38530433)
63. Vestergaard C, Bang K, Gesser B, Yoneyama H, Matsushima K, Larsen CG: A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol 2000;115: 640-646.
64. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, et al: Thymus and activationregulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001;107:535-541. (Pubitemid 32210037)
65. Reefer AJ, Satinover SM, Wilson BB, Woodfolk JA: The relevance of microbial allergens to the IgE antibody repertoire in atopic and nonatopic eczema. J Allergy Clin Immunol 2007;120: 156-163. (Pubitemid 46990492)
66. Mittag D, Scholzen A, Varese N, Baxter L, Paukovics G, Harrison LC, et al: The effector T cell response to ryegrass pollen is counterregulated by simultaneous induction of regulatory T cells. J Immunol 2010;184: 4708-4716.
67. Grindebacke H, Wing K, Andersson AC, Suri-Payer E, Rak S, Rudin A: Defective suppression of Th2 cytokines by CD4+CD25+ regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 2004;34:1364-1372. (Pubitemid 39233690)
68. Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, Arbery J, et al: Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004;363:608-615. (Pubitemid 38264178)
69. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, et al: Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002;3:673-680. (Pubitemid 34752477)
70. Nguyen KD, Vanichsarn C, Nadeau KC: TSLP directly impairs pulmonary Treg function: association with aberrant tolerogenic immunity in asthmatic airway. Allergy Asthma Clin Immunol 2010;6:4.
71. Watanabe N, Wang YH, Lee HK, Ito T, Cao W, Liu YJ: Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 2005;436:1181-1185. (Pubitemid 41232298)
72. Cardona ID, Goleva E, Ou LS, Leung DY: Staphylococcal enterotoxin B inhibits regulatory T cells by inducing glucocorticoid-induced TNF receptor-related protein ligand on monocytes. J Allergy Clin Immunol 2006;117:688-695. (Pubitemid 43340237)
73. Wan YY, Flavell RA: Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007;445:766-770. (Pubitemid 46279706)
74. Joetham A, Matsubara S, Okamoto M, Takeda K, Miyahara N, Dakhama A, et al: Plasticity of regulatory T cells: subversion of suppressive function and conversion to enhancement of lung allergic responses. J Immunol 2008;180:7117-7124.
75. Kim BS, Kim IK, Park YJ, Kim YS, Kim YJ, Chang WS, et al: Conversion of Th2 memory cells into Foxp3+ regulatory T cells suppressing Th2-mediated allergic asthma. Proc Natl Acad Sci USA 2010;107:8742-8747.
76. Xu L, Kitani A, Fuss I, Strober W: Cutting edge: regulatory T cells induce CD4+CD25-Foxp3-T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol 2007; 178:6725-6729. (Pubitemid 46847395)
77. Oyoshi MK, He R, Kumar L, Yoon J, Geha RS: Cellular and molecular mechanisms in atopic dermatitis. Adv Immunol 2009;102:135-226.
78. Ito T, Wang YH, Duramad O, Hori T, Delespesse GJ, Watanabe N, et al: TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 2005;202: 1213-1223. (Pubitemid 41586952)